AR069960A1 - Formulacion farmaceutica de liberacion controlada y procedimiento para su preparacion - Google Patents
Formulacion farmaceutica de liberacion controlada y procedimiento para su preparacionInfo
- Publication number
- AR069960A1 AR069960A1 ARP080105697A ARP080105697A AR069960A1 AR 069960 A1 AR069960 A1 AR 069960A1 AR P080105697 A ARP080105697 A AR P080105697A AR P080105697 A ARP080105697 A AR P080105697A AR 069960 A1 AR069960 A1 AR 069960A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical formulation
- formulation according
- preparation
- alginate
- glycogen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente se refiere a una formulacion farmacéutica de liberacion controlada que comprende por lo menos un principio activo disperso en una matriz que comprende por lo menos un excipiente de liberacion retardada que comprende una asociacion de por lo menos un glucogeno y por lo menos un alginato con sales de metal alcalinotérreo y a un procedimiento para su preparacion. La solicitud se refiere asimismo a un excipiente de liberacion retardada que comprende una asociacion de por lo menos un glucogeno y por lo menos un alginato con sales de metal alcalinotérreo y al procedimiento para su preparacion, y a su utilizacion para la preparacion de formulaciones farmacéuticas de liberacion retardada. Reivindicacion 2: Formulacion farmacéutica segun la reivindicacion 1, en la que dicho glucogeno comprende menos del 1% en peso de azucares reductores. Reivindicacion 7: Formulacion farmacéutica segun cualquiera de las reivindicaciones anteriores, en la que una disolucion acuosa al 1% en peso de dicho alginato presenta una viscosidad dentro del intervalo comprendido entre 50 y 1500 cPs. Reivindicacion 12: Formulacion farmacéutica segun cualquiera de las reivindicaciones anteriores, en la que dicha sal de metal alcalinotérreo se selecciona de entre el grupo constituido por las sales solubles en agua de magnesio, calcio, estroncio y bario. Reivindicacion 18: Formulacion farmacéutica segun cualquiera de las reivindicaciones anteriores, en la que dicho principio activo se selecciona de entre el grupo constituido por analgésicos, antipiréticos, antibioticos, antihistamínicos, ansiolíticos, antiinflamatorios, antiácidos, vasodilatadores, vasoconstrictores, estimulantes, descongestionantes, anticoagulantes, antiarrítmicos, agentes hipoglucémicos, diuréticos, antidepresivos, antiasmáticos, antieméticos y agentes antihipotensores y antiespasmodicos. Reivindicacion 23: Formulacion farmacéutica segun la reivindicacion 22, en la que dicha forma farmacéutica comprende un recubrimiento entérico.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07425828 | 2007-12-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR069960A1 true AR069960A1 (es) | 2010-03-03 |
Family
ID=39522216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080105697A AR069960A1 (es) | 2007-12-28 | 2008-12-23 | Formulacion farmaceutica de liberacion controlada y procedimiento para su preparacion |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8840923B2 (es) |
| EP (1) | EP2234607B1 (es) |
| JP (1) | JP5416716B2 (es) |
| KR (1) | KR101561571B1 (es) |
| CN (1) | CN101909608B (es) |
| AR (1) | AR069960A1 (es) |
| AT (1) | ATE518530T1 (es) |
| AU (1) | AU2008342571B2 (es) |
| BR (1) | BRPI0821454B8 (es) |
| CA (1) | CA2708400C (es) |
| DK (1) | DK2234607T3 (es) |
| EA (1) | EA018975B1 (es) |
| ES (1) | ES2369868T3 (es) |
| GE (1) | GEP20125636B (es) |
| HK (1) | HK1145284A1 (es) |
| IL (1) | IL206124A (es) |
| PL (1) | PL2234607T3 (es) |
| PT (1) | PT2234607E (es) |
| SI (1) | SI2234607T1 (es) |
| UA (1) | UA98684C2 (es) |
| WO (1) | WO2009083561A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010206221B2 (en) | 2009-01-23 | 2016-07-14 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | Controlled release pharmaceutical or food formulation and process for its preparation |
| WO2011015509A1 (en) * | 2009-08-03 | 2011-02-10 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | Food formulation comprising glycogen |
| WO2014172785A1 (en) * | 2013-04-26 | 2014-10-30 | Mirexus Biotechnologies Inc. | Monodisperse glycogen and phytoglycogen nanoparticles and use thereof as additives in cosmetics, pharmaceuticals, and food products |
| CN106137977B (zh) * | 2015-04-28 | 2019-12-13 | 浙江普利药业有限公司 | 海参多糖肠溶微丸及其制备方法 |
| ITUB20152290A1 (it) * | 2015-07-17 | 2017-01-17 | Laboratori Baldacci Spa | Prodotto a base di ferro bisglicinato chelato e acido alginico e/o suoi sali idrosolubili, sue formulazioni ed suoi usi farmaceutici |
| US11865099B2 (en) | 2015-07-17 | 2024-01-09 | Laboratori Baldacci S.P.A. | Product based on iron bis-glycinate chelate and alginic acid and/or water-soluble salts thereof, formulations thereof, and pharmaceutical uses thereof |
| US20190038542A1 (en) * | 2016-02-08 | 2019-02-07 | Mirexus Biotechnologies Inc. | Moisturizing personal care compositions comprising monodisperse phytoglycogen nanoparticles and a further polysaccharide |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3640741A (en) * | 1970-02-24 | 1972-02-08 | Hollister Inc | Composition containing gel |
| DE2062715C3 (de) * | 1970-12-19 | 1974-03-21 | Efeka Friedrich & Kaufmann Arzneimittelfabrik, 3000 Hannover | Verfahren zur Herstellung von oral applizierbaren Arzneimittelzubereitungen mit protrahierter Wirkstoffabgabe und Arzneimittelzubereitung |
| DE3583799D1 (de) * | 1985-01-11 | 1991-09-19 | Abbott Lab Ltd | Feste zubereitung mit langsamer freisetzung. |
| JPS62178505A (ja) | 1986-02-03 | 1987-08-05 | Maruzen Kasei Kk | 化粧料 |
| JPS63290809A (ja) | 1987-05-25 | 1988-11-28 | Noebia:Kk | ***用化粧料 |
| CA2041774C (en) * | 1990-11-27 | 1994-04-19 | Mircea A. Mateescu | Use of cross-linked amylose as a matrix for the slow release of biologically active compounds |
| IT1255488B (it) * | 1992-08-04 | 1995-11-06 | Angelini Francesco Ist Ricerca | Polisaccaridi del glicogeno |
| US5705190A (en) * | 1995-12-19 | 1998-01-06 | Abbott Laboratories | Controlled release formulation for poorly soluble basic drugs |
| US5807575A (en) | 1997-02-14 | 1998-09-15 | Rougier Inc. | Manufacture of cross-linked amylose useful as a excipient for control release of active compounds |
| IT1298758B1 (it) | 1998-03-19 | 2000-02-02 | Angelini Ricerche Spa | Soluzione umettante e lubrificante per uso oftalmico |
| US6607748B1 (en) * | 2000-06-29 | 2003-08-19 | Vincent Lenaerts | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
| AU2001227030A1 (en) * | 2000-11-22 | 2002-06-03 | Lupin Laboratories Limited | Pharmaceutical composition for controlled release of an active ingredient |
| WO2004096127A2 (en) * | 2003-04-25 | 2004-11-11 | Kos Life Sciences, Inc. | Formation of strong superporous hydrogels |
| US20060067917A1 (en) * | 2004-09-20 | 2006-03-30 | Athanassios Sambanis | Insulin delivery system |
| US7687608B2 (en) * | 2005-10-19 | 2010-03-30 | Smartcells, Inc. | Methods for reducing the mitogenicity of lectin compositions |
-
2008
- 2008-12-23 SI SI200830407T patent/SI2234607T1/sl unknown
- 2008-12-23 EA EA201070806A patent/EA018975B1/ru not_active IP Right Cessation
- 2008-12-23 US US12/745,816 patent/US8840923B2/en not_active Expired - Fee Related
- 2008-12-23 AU AU2008342571A patent/AU2008342571B2/en not_active Ceased
- 2008-12-23 CA CA2708400A patent/CA2708400C/en not_active Expired - Fee Related
- 2008-12-23 CN CN2008801227782A patent/CN101909608B/zh not_active Expired - Fee Related
- 2008-12-23 UA UAA201007866A patent/UA98684C2/uk unknown
- 2008-12-23 JP JP2010540124A patent/JP5416716B2/ja not_active Expired - Fee Related
- 2008-12-23 BR BRPI0821454A patent/BRPI0821454B8/pt not_active IP Right Cessation
- 2008-12-23 ES ES08867925T patent/ES2369868T3/es active Active
- 2008-12-23 AR ARP080105697A patent/AR069960A1/es not_active Application Discontinuation
- 2008-12-23 EP EP08867925A patent/EP2234607B1/en active Active
- 2008-12-23 PT PT08867925T patent/PT2234607E/pt unknown
- 2008-12-23 DK DK08867925.3T patent/DK2234607T3/da active
- 2008-12-23 PL PL08867925T patent/PL2234607T3/pl unknown
- 2008-12-23 GE GEAP200811898A patent/GEP20125636B/en unknown
- 2008-12-23 KR KR1020107015913A patent/KR101561571B1/ko active IP Right Grant
- 2008-12-23 AT AT08867925T patent/ATE518530T1/de active
- 2008-12-23 WO PCT/EP2008/068256 patent/WO2009083561A1/en active Application Filing
-
2010
- 2010-06-01 IL IL206124A patent/IL206124A/en active IP Right Grant
- 2010-12-07 HK HK10111374.1A patent/HK1145284A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SI2234607T1 (sl) | 2011-11-30 |
| HK1145284A1 (en) | 2011-04-15 |
| DK2234607T3 (da) | 2011-11-21 |
| AU2008342571A1 (en) | 2009-07-09 |
| IL206124A0 (en) | 2010-11-30 |
| CN101909608B (zh) | 2013-01-23 |
| EA018975B1 (ru) | 2013-12-30 |
| US8840923B2 (en) | 2014-09-23 |
| BRPI0821454A2 (pt) | 2015-06-16 |
| PL2234607T3 (pl) | 2011-12-30 |
| BRPI0821454B1 (pt) | 2020-01-28 |
| ES2369868T3 (es) | 2011-12-07 |
| EA201070806A1 (ru) | 2010-12-30 |
| WO2009083561A1 (en) | 2009-07-09 |
| ATE518530T1 (de) | 2011-08-15 |
| CN101909608A (zh) | 2010-12-08 |
| IL206124A (en) | 2013-01-31 |
| UA98684C2 (uk) | 2012-06-11 |
| JP5416716B2 (ja) | 2014-02-12 |
| KR101561571B1 (ko) | 2015-10-19 |
| BRPI0821454B8 (pt) | 2021-05-25 |
| GEP20125636B (en) | 2012-09-10 |
| CA2708400A1 (en) | 2009-07-09 |
| AU2008342571B2 (en) | 2014-03-13 |
| EP2234607A1 (en) | 2010-10-06 |
| JP2011519820A (ja) | 2011-07-14 |
| CA2708400C (en) | 2016-02-02 |
| PT2234607E (pt) | 2011-09-30 |
| KR20100099728A (ko) | 2010-09-13 |
| EP2234607B1 (en) | 2011-08-03 |
| US20100255083A1 (en) | 2010-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR069960A1 (es) | Formulacion farmaceutica de liberacion controlada y procedimiento para su preparacion | |
| AR075039A1 (es) | Formulacion farmaceutica o alimentaria de liberacion controlada y procedimiento para su preparacion | |
| ES2525530T3 (es) | Sistemas de administración oral de liberación controlada | |
| CA2904335C (en) | Microstructure array for delivery of active agents | |
| WO2011008896A3 (en) | Therapeutic methods using controlled delivery devices having zero order kinetics | |
| CN101657188A (zh) | 固体药物和疫苗剂 | |
| ES2664975T3 (es) | Películas hidrosolubles que comprenden alginatos de baja viscosidad | |
| RU2005135135A (ru) | Композиции, содержащие пиперациллин и тазобактам, применимые для инъекции | |
| AR088381A1 (es) | Formulaciones de etanercept estabilizadas con meglumina | |
| JP2017507165A5 (es) | ||
| JP2012530141A5 (es) | ||
| AR065318A1 (es) | Formulaciones liquidas de formacion de pelicula dermal para liberacion de droga a la piel | |
| AR061771A1 (es) | Sistema de administracion terapeutica | |
| JP2013523677A5 (es) | ||
| CO6361907A2 (es) | Suministro transdermico de farmaco empleando un osmolito y un agente vasoactivo | |
| ES2608382T3 (es) | Mecanismo de seguridad pasiva que utiliza un material con memoria de forma y autofracturable | |
| BR112017026746A2 (pt) | composições de liberação de fármacos implantáveis e métodos de uso dos mesmos | |
| BR112018000067A2 (pt) | dispositivo de liberação de uso único previamente preenchido com um agente reconstituível | |
| BR112016007134A2 (pt) | co-formulações de bifentrina com agentes de proteção de safra encapsulados para uso com fertilizantes líquidos | |
| WO2009001899A1 (ja) | 水性組成物 | |
| JP2008531647A5 (es) | ||
| NZ602441A (en) | A fast dissolving pharmaceutical composition | |
| PE20130403A1 (es) | Comprimido de desintegracion via oral que contiene acarbosa | |
| CN105638792A (zh) | 一种高效杀虫剂 | |
| UY27341A1 (es) | Formulación farmacéutica de sabor enmascarado y procedimiento para su preparación. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |